DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Nimustine

Nimustine

  • Relevance Network Between Chemosensitivity and Transcriptome in Human Hepatoma Cells1

    Relevance Network Between Chemosensitivity and Transcriptome in Human Hepatoma Cells1

  • Title Second-Line Chemotherapy for Small-Cell Lung Cancer

    Title Second-Line Chemotherapy for Small-Cell Lung Cancer

  • Nimustine Induces DNA Breaks and Crosslinks in NIH/3T3 Cells

    Nimustine Induces DNA Breaks and Crosslinks in NIH/3T3 Cells

  • Nanoconjugates Able to Cross the Blood-Brain Barrier Alexander H Stegh, Janina Paula Luciano, Samuel A

    Nanoconjugates Able to Cross the Blood-Brain Barrier Alexander H Stegh, Janina Paula Luciano, Samuel A

  • II. Recurring Tumors

    II. Recurring Tumors

  • Review Article

    Review Article

  • E-Table 1. Drug Classification Category Name Generic Name

    E-Table 1. Drug Classification Category Name Generic Name

  • Ep 3067054 A1

    Ep 3067054 A1

  • Current Challenges and Opportunities in Treating Glioblastomas

    Current Challenges and Opportunities in Treating Glioblastomas

  • EANO Guidelines on the Diagnosis and Treatment of Diffuse Gliomas of Adulthood

    EANO Guidelines on the Diagnosis and Treatment of Diffuse Gliomas of Adulthood

  • Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity Against Human Oral Squamous Cell Carcinoma

    Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity Against Human Oral Squamous Cell Carcinoma

  • Promising Survival for Patients with Glioblastoma Multiforme Treated with Individualised Chemotherapy Based on in Vitro Drug Sensitivity Testing

    Promising Survival for Patients with Glioblastoma Multiforme Treated with Individualised Chemotherapy Based on in Vitro Drug Sensitivity Testing

  • Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels To

    Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels To

  • Liste Des Molécules

    Liste Des Molécules

  • FIGURE 1 Human Subjects with Bispecific Anti-CD 123 X Anti-CD3 Antibodies

    FIGURE 1 Human Subjects with Bispecific Anti-CD 123 X Anti-CD3 Antibodies

  • United States Patent (19) 11 Patent Number: 5,728,680 Morozov Et Al

    United States Patent (19) 11 Patent Number: 5,728,680 Morozov Et Al

  • Supplement 1A. Antineoplastic Medications Samples of the Intervention Group

    Supplement 1A. Antineoplastic Medications Samples of the Intervention Group

  • WO 2010/091198 Al

    WO 2010/091198 Al

Top View
  • List of Cancer Drugs (The First Batch) Ⅰ.Cancer Drugs
  • Induction of Oxidative Stress by Anticancer Drugs in the Presence and Absence of Cells
  • Handling Cytostatic Drugs: Contents
  • Nimustine Hydrochloride (Rinnm) C12H10F3N3O4 = 317.2
  • From Old Alkylating Agents to New Minor Groove Binders
  • Clinical Study : Phase II Study of Continuous ACNU (Nimustine) And
  • Liste Des Molécules
  • Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma
  • Phenytoin Reduces 5-Ala Mediated Fluorescence in Glioblastoma Cells
  • Molecular Targeting Chemotherany for Glioblastoma
  • Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
  • 3.1 Basic Principles of Chemotherapy
  • Impact of ROS Generated by Chemical, Physical, and Plasma Techniques on Cancer Attenuation
  • Molecular Blueprints for Antitumor Drugs
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0077820 A1 Danter Et Al
  • What Is the Advance of Extent of Resection in Glioblastoma Surgical Treatment—A Systematic Review
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0213382 A1 Rudy Et Al
  • Modified Conditioning Regimen with Idarubicin Followed by Autologous


© 2024 Docslib.org    Feedback